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T
his month we publish the 
ﬁ  ndings of a major study 
estimating the likely trends in 
global morbidity and mortality [1]. 
Such a study should surely cause us, 
as editors, to pause and reﬂ  ect on the 
implications for what we should be 
publishing. Which medical conditions 
will be the major causes of death and 
disease, and is PLoS Medicine publishing 
key research studies addressing those 
conditions? Ideally, as a general 
medical journal, the proportion of 
research on different diseases that we 
publish should be roughly equivalent to 
their contribution to the global burden 
of disease. In other words, we have to 
ask, “Are we publishing the right stuff?”
Mathers and Loncar [1] have 
updated the much-cited Global Burden 
of Disease (GBD) study published a 
decade ago [2]. They have produced 
alternative baseline, optimistic, and 
pessimistic projections for mortality 
and for the burden of disease, 
measured in terms of disability-adjusted 
life years (DALYs). Researchers, policy 
makers, and others will often need 
to consult these revised projections 
and we are delighted that the authors 
have chosen to publish them in an 
open-access journal. An important 
feature of many PLoS articles is that 
supplementary ﬁ  les are also freely 
available. The supporting documents 
accompanying the Mathers and Loncar 
article contain a wealth of detailed 
information and it is essential that such 
data is placed in the public domain. 
With minor modiﬁ  cations, Mathers 
and Loncar have adopted the same 
methodology as was used in the earlier 
GBD study. This is not a radical new 
“take” on the issue and we should not 
be surprised that no major changes in 
the GBD estimates have emerged.
However, the ﬁ  ndings conﬁ  rm that 
the burden of morbidity and mortality 
that is due to HIV/AIDS will be 
substantially higher than estimated in 
the original GBD study. Small declines 
in the total burden of morbidity 
and mortality due to a number of 
other causes will result in the overall 
projections for mortality for 2030 
remaining much the same as predicted 
earlier. In the baseline projection, by 
2015, HIV/AIDS will be the leading 
cause of burden of disease in both low- 
and middle-income countries, but the 
predicted rise in tobacco-attributable 
deaths means that, globally, tobacco 
will kill 50% more people than HIV/
AIDS. The three leading causes of 
burden of disease in 2030 are projected 
to be HIV/AIDS, unipolar depressive 
disorders, and ischemic heart disease. 
Road trafﬁ  c accidents are the fourth 
leading cause in the baseline scenario, 
and the third leading cause, ahead of 
ischemic heart disease, in the optimistic 
scenario.
An inspection of the research 
published in PLoS Medicine in recent 
months shows that we are indeed 
giving due attention to HIV/AIDS 
and to other infectious diseases. But 
we need to publish more research on 
cardiovascular disease, diabetes, mental 
health, road trafﬁ  c accidents, and 
chronic obstructive pulmonary disease. 
It has been interesting to observe 
that some medical specialties more 
than others have chosen to submit 
their work to us. In particular, 
researchers from the infectious 
diseases, epidemiology, and public 
health communities have shown strong 
support for the journal. One reason 
for this support might be that, for 
example, AIDS researchers—all too 
aware that HIV is most prevalent in the 
world’s poorest countries—have more 
swiftly grasped the need to make the 
results of research freely available to all. 
Nonetheless, the advantages of open 
access apply to all disciplines.
But the implications of the ﬁ  ndings 
of Mathers and Loncar obviously go 
considerably beyond the content 
of this or any other journal. Their 
report should help set the agenda 
for policy and establish the priorities 
for research. But will it? Sadly, it is all 
too clear that the greatest needs are 
generally not those that receive the 
greatest attention. Most notably, only 
10% of expenditure on health research 
and development is devoted to the 
problems that primarily affect the 
poorest 90% of the world’s population 
[3]. 
Mathers and Loncar caution that 
continued economic and social 
development is required for further 
progress to be made in reducing the 
global burden, and they stress that 
they have worked on the assumption 
that such development will lead to 
improved health in the developing 
world, in the same manner that it has 
done in richer nations. Global climate 
change and the dwindling of key 
resources (notably oil) could very well 
hold back economic growth and put 
development efforts off-track. There 
are many “unknowns”—including 
international conﬂ  ict—that can never 
be factored into the calculations of 
those who are brave enough to seek to 
predict the future.
Things could be much worse than 
the most pessimistic of the report’s 
three alternative projections, most 
notably if the levels of economic 
growth that they have assumed are not 
attained. But they could also be much 
better than even the most optimistic 
projection. This would require many 
institutions and individuals also to 
“do the right stuff.” Identifying the 
problems is a good place to start, but it 
must now lead on to the development 
of constructive policies and to 
collaborative action.  
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